|
US20070014787A1
(en)
*
|
1998-07-15 |
2007-01-18 |
Human Genome Sciences, Inc. |
71 human secreted proteins
|
|
US7479555B2
(en)
|
1999-07-21 |
2009-01-20 |
Ceres, Inc. |
Polynucleotides having a nucleotide sequence that encodes a polypeptide having MOV34 family activity
|
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
|
US7442777B2
(en)
|
2000-11-29 |
2008-10-28 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7431923B2
(en)
|
2005-01-03 |
2008-10-07 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
US7534429B2
(en)
|
2000-11-29 |
2009-05-19 |
Hoffmann-La Roche Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
|
EP1448600A4
(en)
|
2001-09-07 |
2004-12-22 |
Bristol Myers Squibb Co |
POLYNUCLEOTIDE ENCODING A NOVEL HUMAN G PROTEIN-RELATED RECEPTOR, HGPRMBY39
|
|
WO2004013311A2
(en)
*
|
2002-08-06 |
2004-02-12 |
Diadexus, Inc. |
Compositions and methods relating to ovarian specific genes and proteins
|
|
US20050037946A1
(en)
*
|
2003-01-13 |
2005-02-17 |
Millennium Pharmaceuticals, Inc. |
Methods and compositions for treating cardiovascular disease using 1722, 10280, 59917, 85553, 10653, 9235, 21668, 17794, 2210, 6169, 10102, 21061, 17662, 1468, 12282, 6350, 9035, 1820, 23652, 7301, 8925, 8701, 3533, 9462, 9123, 12788, 17729, 65552, 1261, 21476, 33770, 9380, 2569654, 33556, 53656, 44143, 32612, 10671, 261, 44570, 41922, 2552, 2417, 19319, 43969, 8921, 8993, 955, 32345, 966, 1920, 17318, 1510, 14180, 26005, 554, 16408, 42028, 112091, 13886, 13942, 1673, 54946 or 2419
|
|
US7094572B2
(en)
|
2003-03-14 |
2006-08-22 |
Bristol-Myers Squibb |
Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74
|
|
ITRM20030149A1
(it)
|
2003-04-02 |
2004-10-03 |
Giuliani Spa |
Oligonucleotidi (odn) antisenso per smad7 e loro usi in campo medico
|
|
WO2005019258A2
(en)
*
|
2003-08-11 |
2005-03-03 |
Genentech, Inc. |
Compositions and methods for the treatment of immune related diseases
|
|
US20050186577A1
(en)
|
2004-02-20 |
2005-08-25 |
Yixin Wang |
Breast cancer prognostics
|
|
US7306923B2
(en)
*
|
2004-06-14 |
2007-12-11 |
Galapagos N.V. |
Methods for identification, and compounds useful for the treatment of degenerative & inflammatory diseases
|
|
JP2008503241A
(ja)
|
2004-06-21 |
2008-02-07 |
エクセリクシス， インク． |
ＰＴＥＮ経路のモディファイヤーとしてのＰＧＤｓおよび使用方法
|
|
JPWO2006006477A1
(ja)
*
|
2004-07-09 |
2008-04-24 |
国立大学法人三重大学 |
骨疾患又は関節疾患に関与するポリペプチド及びそのｄｎａ
|
|
CA2572816A1
(en)
*
|
2004-07-16 |
2006-01-26 |
Val-Chum, S.E.C. |
Use of lamin b1 nuclear antigen, fragments and compositions thereof, for inhibiting or reducing a trombotic event
|
|
WO2006072946A2
(en)
*
|
2005-01-04 |
2006-07-13 |
Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science |
Hsp60, hsp60 peptides and t cell vaccines for immunomodulation
|
|
US7795503B2
(en)
|
2005-02-22 |
2010-09-14 |
Ceres, Inc. |
Modulating plant alkaloids
|
|
EP1851543A2
(en)
|
2005-02-24 |
2007-11-07 |
Compugen Ltd. |
Novel diagnostic markers, especially for in vivo imaging, and assays and methods of use thereof
|
|
GB0510627D0
(en)
|
2005-05-25 |
2005-06-29 |
Avidex Ltd |
Polypeptides
|
|
US8124839B2
(en)
|
2005-06-08 |
2012-02-28 |
Ceres, Inc. |
Identification of terpenoid-biosynthesis related regulatory protein-regulatory region associations
|
|
WO2007021807A1
(en)
*
|
2005-08-12 |
2007-02-22 |
Schering Corporation |
Mcp1 fusions
|
|
GB0519376D0
(en)
*
|
2005-09-23 |
2005-11-02 |
Astrazeneca Ab |
Diagnostic method
|
|
US8110184B2
(en)
*
|
2005-09-30 |
2012-02-07 |
University Of Kentucky Research Foundation |
Ex vivo and in vivo methods and related compositions for generating hematopoietic stem cell populations
|
|
EP1945754B1
(en)
|
2005-10-31 |
2014-07-23 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
|
US20070192885A1
(en)
*
|
2006-01-26 |
2007-08-16 |
Daniel Chelsky |
TAT-039 and methods of assessing and treating cancer
|
|
JP5146944B2
(ja)
*
|
2006-03-20 |
2013-02-20 |
独立行政法人理化学研究所 |
Ｉｐ３受容体結合タンパク質による細胞内標的分子の制御
|
|
CA2647769C
(en)
|
2006-03-20 |
2015-05-26 |
Japan Science And Technology Agency |
Control of intracellular target molecule by ip3 receptor-binding protein
|
|
EP2006380A4
(en)
|
2006-03-23 |
2010-08-11 |
Kyowa Hakko Kirin Co Ltd |
AGONIST ANTIBODY AGAINST THE HUMAN THROMBOPOIETINE RECEPTOR
|
|
US20070237713A1
(en)
|
2006-04-04 |
2007-10-11 |
Fan Rong A |
PCan065 Antibody Compositions and Methods of Use
|
|
US7919092B2
(en)
|
2006-06-13 |
2011-04-05 |
Oncomed Pharmaceuticals, Inc. |
Antibodies to notch receptors
|
|
JP4997547B2
(ja)
|
2006-06-15 |
2012-08-08 |
独立行政法人理化学研究所 |
炎症性疾患の判定方法
|
|
FR2908654B1
(fr)
|
2006-11-20 |
2014-04-04 |
Oreal |
Utilisation cosmetique de proteines de type chitinase
|
|
AU2007327109A1
(en)
*
|
2006-11-29 |
2008-06-05 |
Medical Research Council |
Assay
|
|
WO2008079406A2
(en)
*
|
2006-12-19 |
2008-07-03 |
Genentech, Inc. |
Gene expression markers for inflammatory bowel disease
|
|
WO2008091641A2
(en)
|
2007-01-24 |
2008-07-31 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
EP2106439B1
(en)
|
2007-01-24 |
2014-11-12 |
The Regents of the University of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
|
WO2008092214A1
(en)
*
|
2007-02-02 |
2008-08-07 |
Minomic International Limited |
Biomarkers for diabetes
|
|
WO2008100563A2
(en)
*
|
2007-02-14 |
2008-08-21 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for diagnosing and treating cancer
|
|
JP5378202B2
(ja)
*
|
2007-03-15 |
2013-12-25 |
株式会社リバース・プロテオミクス研究所 |
脳・神経に特異的あるいは神経分化に特異的なバイオマーカー
|
|
US8545888B2
(en)
*
|
2007-06-14 |
2013-10-01 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Tendon stem cells
|
|
AU2008291682B2
(en)
*
|
2007-08-24 |
2012-09-13 |
Mylexa Pty Limited |
Modulators of hypersensitivity reactions
|
|
JP2009055838A
(ja)
*
|
2007-08-31 |
2009-03-19 |
Nipro Corp |
融合タンパク質、該融合タンパク質に関連する遺伝子、ベクター、形質転換体及び抗炎症性医薬組成物
|
|
SG193860A1
(en)
|
2008-06-04 |
2013-10-30 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
|
CN102112490B
(zh)
|
2008-07-08 |
2014-10-22 |
昂考梅德药品有限公司 |
Notch1受体结合剂和其使用方法
|
|
US9132189B2
(en)
|
2008-07-08 |
2015-09-15 |
Oncomed Pharmaceuticals, Inc. |
Notch1 binding agents and methods of use thereof
|
|
NZ592009A
(en)
|
2008-10-10 |
2012-11-30 |
Amgen Inc |
Fgf21 mutants and uses thereof
|
|
JP2012507299A
(ja)
|
2008-10-31 |
2012-03-29 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
Ｌｉｇｈｔ標的分子およびその使用
|
|
CN102239414A
(zh)
|
2008-12-04 |
2011-11-09 |
赛诺菲-安万特 |
牵涉血红素结合蛋白1的方法和用途
|
|
WO2010067308A2
(en)
|
2008-12-08 |
2010-06-17 |
Compugen Ltd. |
Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologics
|
|
AU2010246038A1
(en)
|
2009-05-05 |
2011-12-01 |
Amgen Inc. |
FGF21 mutants and uses thereof
|
|
BRPI1011404B1
(pt)
|
2009-05-05 |
2022-05-03 |
Amgen Inc |
Polipeptídeos mutantes fgf21, polipeptídeo de fusão, multímero, composição farmacêutica, ácido nucleico isolado, vetor e célula hospedeira
|
|
WO2010129890A2
(en)
*
|
2009-05-08 |
2010-11-11 |
Virginia Tech Intellectual Properties, Inc. |
Compounds and methods for inhibiting platelet aggregation
|
|
WO2010141999A1
(en)
*
|
2009-06-12 |
2010-12-16 |
The University Of Queensland |
Agents and methods for diagnosing and treating ankylosing spondylitis
|
|
JP2012530493A
(ja)
|
2009-06-17 |
2012-12-06 |
アムジエン・インコーポレーテツド |
キメラポリペプチドおよびその使用
|
|
HUE041426T2
(hu)
|
2009-11-02 |
2019-05-28 |
Univ Washington |
Terápiás nukleáz-készítmények és eljárások
|
|
MX2012006397A
(es)
*
|
2009-12-02 |
2012-11-30 |
Amgen Inc |
PROTEINAS DE ENLACE QUE ENLAZAN A FGFR1C HUMANO, ß-KLOTHO HUMANA Y TANTO FGFR1C HUMANO COMO ß-KLOTHO HUMANA.
|
|
UA109888C2
(uk)
|
2009-12-07 |
2015-10-26 |
|
ІЗОЛЬОВАНЕ АНТИТІЛО АБО ЙОГО ФРАГМЕНТ, ЩО ЗВ'ЯЗУЄТЬСЯ З β-КЛОТО, РЕЦЕПТОРАМИ FGF І ЇХНІМИ КОМПЛЕКСАМИ
|
|
MX2012008085A
(es)
|
2010-01-13 |
2012-09-12 |
Oncomed Pharm Inc |
Agentes de union notch1 y metodos de uso de los mismos.
|
|
CN102725658B
(zh)
|
2010-01-28 |
2014-09-03 |
佳能株式会社 |
闪烁体结晶体、其制造方法和放射线检测器
|
|
CA2695337A1
(en)
*
|
2010-03-04 |
2011-09-04 |
Ian De Belle |
Compositions and methods for inhibition of hiv
|
|
US8524217B2
(en)
|
2010-05-11 |
2013-09-03 |
Merck Sharp & Dohme Corp. |
MCP1-Ig fusion variants
|
|
EP2596123B1
(en)
|
2010-07-22 |
2015-11-25 |
Shire Human Genetic Therapies, Inc. |
Crystal structure of human alpha-n-acetylglucosaminidase
|
|
PY1147875A
(es)
|
2010-11-08 |
2015-08-03 |
Novartis Ag |
Polipéptidos de enlace de los receptores de quimiocina
|
|
WO2012090150A2
(en)
*
|
2010-12-27 |
2012-07-05 |
Compugen Ltd |
New cell-penetrating peptides and uses thereof
|
|
IT1406405B1
(it)
*
|
2010-12-27 |
2014-02-21 |
Univ Roma |
Molecole peptidiche per il trattamento di patologie mitocondriali
|
|
CA2834626A1
(en)
|
2011-04-29 |
2012-11-01 |
University Of Washington |
Therapeutic nuclease compositions and methods
|
|
CA2835477A1
(en)
*
|
2011-05-13 |
2012-11-22 |
Inserm (Institut National De La Sante Et De La Recherche Medicale) |
Method for the diagnosis of early rheumatoid arthritis
|
|
US9328174B2
(en)
|
2012-05-09 |
2016-05-03 |
Novartis Ag |
Chemokine receptor binding polypeptides
|
|
TW201726746A
(zh)
|
2012-11-07 |
2017-08-01 |
輝瑞股份有限公司 |
抗切口３（ａｎｔｉ-ｎｏｔｃｈ３）抗體及抗體-藥物共軛體
|
|
ES3066738T3
(en)
|
2012-12-21 |
2026-05-14 |
Aveo Pharmaceuticals Inc |
Anti-gdf15 antibodies
|
|
EP2970468B1
(en)
|
2013-03-13 |
2021-07-07 |
Novartis AG |
Notch2 binding molecules for treating respiratory diseases
|
|
SI3063275T1
(sl)
|
2013-10-31 |
2020-02-28 |
Resolve Therapeutics, Llc |
Terapevtske fuzije nukleaza-albumin in postopki
|
|
RU2016128557A
(ru)
*
|
2013-12-29 |
2018-02-01 |
Кьюрлаб Онколоджи, Инк. |
МЕТОДЫ И КОМПОЗИЦИИ, СВЯЗАННЫЕ С p62 / SQSTM1, ДЛЯ ЛЕЧЕНИЯ И ПРОФИЛАКТИКИ ЗАБОЛЕВАНИЙ, АССОЦИИРОВАННЫХ С ВОСПАЛЕНИЕМ
|
|
WO2015158006A1
(zh)
*
|
2014-04-18 |
2015-10-22 |
烟台聚杰生物工程有限公司 |
15种男性生育相关蛋白或其组合的应用
|
|
JP6910800B2
(ja)
|
2014-06-20 |
2021-07-28 |
アベオ ファーマシューティカルズ， インコーポレイテッド |
Ｇｄｆ１５調節剤を用いたうっ血性心不全及びその他の心機能不全の治療
|
|
EA201790342A1
(ru)
|
2014-08-08 |
2017-07-31 |
ЭЛЕКТОР ЭлЭлСи |
Антитела к trem2 и способы их применения
|
|
GB201508025D0
(en)
|
2015-05-11 |
2015-06-24 |
Ucl Business Plc |
Fabry disease gene therapy
|
|
PT3445397T
(pt)
|
2016-04-22 |
2023-01-13 |
Vaccinex Inc |
Exibição de proteína integral de membrana sobre viriões envelopados extracelulares de poxvírus
|
|
MA45554A
(fr)
|
2016-07-01 |
2019-05-08 |
Resolve Therapeutics Llc |
Fusions de binucléase optimisées.
|
|
KR102033215B1
(ko)
*
|
2016-07-05 |
2019-10-16 |
성균관대학교산학협력단 |
건선 유발 동물 모델 및 이의 용도
|
|
GB201700567D0
(en)
*
|
2017-01-12 |
2017-03-01 |
Genagon Therapeutics Ab |
Therapeutic agents
|
|
US11629340B2
(en)
|
2017-03-03 |
2023-04-18 |
Obsidian Therapeutics, Inc. |
DHFR tunable protein regulation
|
|
KR20200018488A
(ko)
|
2017-05-24 |
2020-02-19 |
토리스 게엠베하 |
고암모니아혈증을 치료하기 위한 글루타민 합성효소의 용도
|
|
HUE062436T2
(hu)
|
2017-08-03 |
2023-11-28 |
Alector Llc |
Anti-trem2 antitestek és alkalmazási módszereik
|
|
CN111315767B
(zh)
|
2017-08-22 |
2025-03-18 |
萨纳生物有限责任公司 |
可溶性干扰素受体及其用途
|
|
WO2020069373A1
(en)
|
2018-09-28 |
2020-04-02 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
WO2020069339A1
(en)
|
2018-09-28 |
2020-04-02 |
President And Fellows Of Harvard College |
Mutant reverse tetracycline transactivators for expression of genes
|
|
US12274733B2
(en)
|
2018-09-28 |
2025-04-15 |
President And Fellows Of Harvard College |
Cellular reprogramming to reverse aging and promote organ and tissue regeneration
|
|
US20210388345A1
(en)
*
|
2018-10-22 |
2021-12-16 |
Roche Sequencing Solutions, Inc. |
Profiling of rheumatoid arthritis autoantibody repertoire and peptide classifiers therefor
|
|
WO2020178426A1
(en)
*
|
2019-03-07 |
2020-09-10 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
New vaccinal strategy to prevent or treat rheumatoid arthritis
|
|
CA3164500A1
(en)
*
|
2020-01-21 |
2021-07-29 |
Kai Christoph Wollert |
Myeloid-derived growth factor for use in treating or preventing fibrosis, hypertrophy or heart failure
|
|
WO2022125592A1
(en)
*
|
2020-12-07 |
2022-06-16 |
The Research Foundation for the State Universtiy of New York |
Methods of making water-soluble protein formed in a bacterial expression system, compositions, and methods of use thereof
|
|
US12252518B2
(en)
|
2023-01-06 |
2025-03-18 |
Life Biosciences, Inc. |
Methods of treating non-arteritic anterior ischemic optic neuropathy
|
|
CN121263198A
(zh)
*
|
2023-05-08 |
2026-01-02 |
卡努佩免疫治疗公司 |
用于治疗免疫性血小板减少的Ig样融合蛋白
|
|
EP4789018A1
(en)
*
|
2023-10-02 |
2026-08-12 |
Animate Biosciences, Inc. |
Peptides from regenerative species and methods for use thereof
|